Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide
Endocrine Abstracts · 04.03.2026
DOI: 10.1530/endoabs.116.o6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von MD Richard Vaca, und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vaca,, M. R., Contento,, M. M., Wolin,, M. E., MD, Gallagher,, P. E., & Corbett,, M. V. (2026). Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.o6
Vancouver
Vaca, MR, Contento, MM, Wolin, ME, MD, Gallagher, PE, Corbett, MV. Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.o6
BibTeX
@article{Vaca2026,
author = {Vaca,, MD Richard and Contento,, MD Marissa and Wolin,, MD Edward and MD and Gallagher,, PhD Emily and Corbett,, MD Virginia},
title = {Effect of GLP-1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.116.o6}
}
EUVIMED